ÂÜÀòÂÒÂ×

Bryan has over 20 years of combined experience in the Biotechnology and Pharmaceutical industries, including as a postdoctoral fellow at Stanford University focusing on cancer therapeutics and signaling mechanisms, as a scientist at Hyseq/Nuvelo Inc. identifying novel drug targets, and as an attorney at both prestigious international and IP boutique law firms where he concentrated on intellectual property prosecution and technology-based and general litigation. Bryan is a graduate of the University of California at Berkeley, received both his MS in Physiology & Biophysics and PhD in Pharmacology from Georgetown University, and his JD magna cum laude from the Santa Clara University School of Law.